Metals and oxidative homeostasis in Alzheimer's disease

Drug Development Research

Volumn 56, Issue 3, 2002, Pages 293-299

  Perry, George ^a   Cash, Adam D ^a   Srinivas, Ravi ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Free radicals; Iron; Mitochondria; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; CHELATING AGENT; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME C OXIDASE; FREE RADICAL; GLUTATHIONE; HYDROGEN PEROXIDE; IRON; MANGANESE SUPEROXIDE DISMUTASE; SUPEROXIDE;

ALZHEIMER DISEASE; COPPER METABOLISM; GENE THERAPY; HOMEOSTASIS; HUMAN; IRON METABOLISM; MACROMOLECULE; METAL METABOLISM; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; REVIEW;

EID: 0036659999     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10099     Document Type: Review

References (62)

1. Atwood CS, Moir RD, Huang X, et al. 1998. Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273:12817-12826.
2. Bondy SC, Guo-Ross SX, Truong AT. 1998. Promotion of transition metal-induced reactive oxygen species formation by β-amyloid. Brain Res 799:91-96.
3. Brown DR, Qin K, Herms JW, et al. 1997. The cellular prion protein binds copper in vivo. Nature 390:684-687.
4. Bruijn LI, Houseweart MK, Kato S, et al. 1998. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281:1851-1854.
5. Calhoun ME, Wiederhold KH, Abramowski D, et al. 1998. Neuron loss in APP transgenic mice. Nature 395:755-756.
6. Castellani RJ, Smith MA, Nunomura A, et al. 1999. Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? Free Radic Biol Med 26:1508-1512.
7. Castellani RJ, Harris PLR, Lecrosiey A, et al. 2000a. Evidence for a novel heine-binding protein, HasAh, in Alzheimer disease. Antiox Redox Signal 2:137-142.
8. Castellani RJ, Siedlak SL, Perry G, Smith MA. 2000b. Sequestration of iron by Lewy bodies in Parkinson's disease. Acta Neuropathol 100:11-1114.
9. Cherny RA, Legg JT, McLean CA, et al. 1999. Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion. J Biol Chem 274:23223-23228.
10. Cizewski Culotta V, Klomp LWJ, Strain J, Casareno RLB, Krems B, Gitlin JD. 1997. The copper chaperone for superoxide dismutase. J Biol Chem 272:23469-23472.
11. Corson LN, Folmer J, Strain JJ, et al. 1999. Oxidative stress and iron are implicated in fragmenting vacuoles of Saccharomyces cerevisiae lacking Cu,Zn-superoxide dismutase. J Biol Chem 274:27590-27596.
12. De Leo ME, Borrello S, Passantino M, et al. 1998. Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease. Neurosci Lett 250:173-176.
13. Dikalov SI, Vitek MP, Maples KR, Mason RP. 1999. Amyloid β peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides. J Biol Chem 274:9392-9999.
14. Flood DG, Reaume AG, Gruner JA, et al. 1999, Hindlimb motor neurons require Cu/Zn superoxide dismutase for maintenance of neuromuscular junctions. Am J Pathol 155:663-672.
15. Huang X, Atwood CS, Hartshorn MA, et al. 1999a. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Bioehemistry 38:7609-7616.
16. Huang X, Cuajungco MP, Atwood CS, et al. 1999b. Cu(II) potentiation of Alzheimer Aβ neurotoxicity. J Biol Chem 274:37111-37116.
17. Irizarry MC, McNamara M, Fedorchak K, et al. 1997a. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56:965-973.
18. Irizarry MC, Soriano F, McNamara M, et al. 1997b. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 17:7053-7059.
19. Kawamata T, Tooyama I, Yamada T, et al. 1993. Lactotransferin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol 142:1574-1585.
20. Kim HT, Russell RL, Raina AK, et al. 2000. Protein disulfide isomerase in Alzheimer disease. Antiox Redox Signal 2:485-489.
21. Loeffler DA, LeWitt PA, Juneau PL, et al. 1996. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 738:265-274.
22. Lovell MA, Robertson JD, Teesdale WJ, et al. 1998. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158:47-52.
23. Mantyh PW, Ghilardi JR, Rogers S, et al. 1993. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem 61:1171-1174.
24. Martins RN, Harper CG, Stokes GB, Masters CL. 1986. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J Neurochem 46:1042-1045.
25. Melov S, Schneider JA, Day BJ, et al. 1998. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 18:159-163.
26. Moir RD, Atwood CS, Romano DM, et al. 1999. Differential effects of apolipoprotein E isoforms on metal-induced aggregation of Aβ using physiological concentrations. Biochemistry 38:4595-4603.
27. Multhaup G, Ruppert T, Schlicksupp A, et al. 1998, Copper-binding amyloid precursor undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry 37:7224-7230.
28. Nunomura A, Perry G, Pappolla MA, et al. 1999a. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer disease. J Neurosci 19:1959-1964.
29. Nunomura A, Perry G, Smith MA. 1999b. Oxidation of nucleic acids in neurons precedes amyloid β deposition in Down syndrome. J Neuropathol Exp Neurol 58:511.
30. Numomura A, Perry G, Smith MA, Chiba S. 2000a. Oxidative damage and amyloid β deposition in Alzheimer disease with reference to apolipoprotein E4 (Japanese). Dementia 14:232.
31. Nunomura A, Chiba S, Lippa C, et al. 2000b. Increasing amyloid β 42 deposition is associated with decreasing neuronal RNA oxidation in Down's syndrome and familial Alzheimer's disease. Brain Pathol 10:783.
32. Nunomura A, Perry G, Hirai K, et al. 2000c. Neuronal oxidative stress precedes amyloid-β deposition in Down's syndrome, J Neuropathol Exp Neurol 59:1011-1017.
33. Nunomura A, Perry G, Aliev G, et al. 2001. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759-767.
34. Odetti P, Garibaldi S, Norese R, et al. 2000. Lipoperoxidation is selectively involved in progressive supranuclear palsy. J Neuropathol Exp Neurol 59:393-397.
35. Perez M, Valpuesta JM, de Gareini EM, et al. 1998. Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy. Am J Pathol 152:1531-1539.
36. Perry G, Castellani RJ, Hirai K, Smith MA. 1998. Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheimer Dis 1:45-55.
37. Perry G, Raina AK, Nunomura A, et al. 2000a. How important is oxidative damage? Lessons from Alzheimer disease. Free Radic Biol Med 28:831-834.
38. Perry G, Nunomura A, Raina AK, Smith MA. 2000b, Amyloid-β junkies. Lancet 355:757.
39. Qian ZM, Wang Q. 1998. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Rev 27:257-267.
40. Raina AK, Templeton DJ, Deak JC, et al. 1999. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. Redox Report 4:23-27.
41. Rottkamp CA, Raina AK, Zhu X, et al. 2001. Redox-active iron mediates amyloid-β toxicity. Free Radic Biol Med 30:447-450.
42. Russell RL, Siedlak SL, Raina AK, et al. 1999. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch Biochem Biophys 370:236-239.
43. Sampson JB, Ye Y, Rosen H, Beckman JS. 1998. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch Biochem Biophys 356:207-213.
44. Sayre LM, Zelasko DA, Harris PLR, et al. 1997a. 4-Hydroxnonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68:2092-2097.
45. Sayre LM, Zagorski MG, Surewicz WK, et al. 1997b. Mechanisms of neurotoxicity associated with amyloid β deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal. Chem Res Toxicol 10:518-526.
46. Sayre LM, Perry G, Harris PLR, et al. 2000. In situ redox catalysis by neurofibrillary tangles and senile plaques in Alzheimer disease: a central role for bound transition metals. J Neurochem 74:270-279.
47. Smith MA, Taneda S, Richey PL, et al. 1994. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91:5710-5714.
48. Smith MA, Harris PLR, Sayre LM, et al. 1997a. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17:2653-2657.
49. Smith MA, Harris PLR, Sayre LM, Perry G. 1997b. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Nad Acad Sci USA 94:9866-9868.
50. Smith MA, Wehr K, Harris PLR, et al. 1998a. Abnormal localization of iron regulatory protein (IRP) in Alzheimer disease. Brain Res 788:232-236.
51. Smith MA, Sayre LM, Anderson VE, et al. 1998b. Cytochemical demonstration of oxidative damage in Alzheimer disease by imnmnochemical enhancement of the carbonyl reaction with dinitrophenylhydrazine. J Histochem Cytochem 46:731-735.
52. Smith MA, Hirai K, Hsiao K, et al. 1998c. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70:2212-2215.
53. Takeda A, Smith MA, Avila J, et al. 2000. In Alzheimer disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J Neurochem 75:1234-1241.
54. Varadarajan S, Yatin S, Kanski J, et al. 1999, Methionine residue 35 is important in amyloid β-peptide-associated free radical oxidative stress. Brain Res Bull 50:133-141.
55. Wang P, Chen H, Qin H, et al. 1998. Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proe Natl Acad Sci USA 95:4556-4560.
56. White AR, Bush AI, Beyreuther K, et al. 1999a. Exacerbation of copper toxicity in primary neuronal cultures depleted of cellular glutathione. J Neurochem 72:2092-2098.
57. White AR, Reyes R, Mercer JFB, et al. 1999b. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res 842:439-444.
58. Williams MD, Van Remmen H, Conrad CC, et al. 1998. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem 273:28510-28515.
59. Wong B-S, Liu T, Li R, et al. 2001a. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 76:565-572.
60. Wong B-S, Liu T, Paisley D, et al. 2001b. Induction of heme oxygenase-1 and neuronal nitric oxide synthase in Doppelexpressing mice devoid of prion protein: implications for Doppel function. Mol Cell Neurosci 17:768-775.
61. Yang EY, Guo-Ross SX, Bondy SC. 1999. The stabilization of ferrous iron by a toxic β-amyloid fragment and by an aluminum salt. Brain Res 839:221-226.
62. Yatin SM, Varadarajan S, Link CD, Butterfield DA. 1999. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide(1-42). Neurobiol Aging 20:325-330.